Justin J. McAnear - 22 Aug 2024 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Reporting relationship: Former Chief Financial Officer
Issuer ticker: TXG
Reported as of: 22 Aug 2024
Net transaction value: -$66,710
SEC form: 4
Accepted by SEC: 26 Aug 2024, 17:03:29 UTC
Prior SEC filing: 23 May 2024
Next SEC filing: 16 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/ Eric S. Whitaker, as Attorney-in-Fact for Justin J. McAnear

Key filing fact

Justin J. McAnear filed Form 4 for 10x Genomics, Inc. (TXG) on 26 Aug 2024.

Key facts

This page summarizes Justin J. McAnear's Form 4 filing for 10x Genomics, Inc. (TXG).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 26 Aug 2024, 17:03.

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

Shares, units, or other non-derivative securities reported in this filing.

TXG transaction

Sale

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Section 16 status

Justin J. McAnear is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 1 footnote

Footnote F1

The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.